Longeveron
LGVN • NASDAQ
Longeveron is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephen H. Willard, with a market cap of $32.5M.
Market Cap$32.5M
Employees24.0
CEOStephen H. Willard
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Longeveron FAQ
Common questions about Longeveron
Longeveron is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $327.6K.
Longeveron has approximately 24 employees.